Salvia BioElectronics
Netherlands - EindhovenMedical Devices
Focus: Salvia BioElectronics develops the PRIMUS implantable neurostimulator system, a medical device targeting chronic migraine and cluster headache indications. The company is a Series B stage neurotech specialist based in Eindhoven, Netherlands, competing in the emerging bioelectronic medicine segment.
Profile data last refreshed 18m ago · AI intelligence enriched 3w ago
Funding Stage
SERIES B
Open Jobs
3+1 this month
Stable — net +1 jobs in 30d
1 added, 0 removed. Backfill posture.
Should You Work at Salvia BioElectronics?
AI assessmentSalvia is a specialist neurotech play suited for early-stage risk-tolerant professionals seeking deep technical ownership in an emerging bioelectronic medicine niche, but limited hiring scale and pre-commercialization stage mean job security and promotion velocity are uncertain.
Why Work Here
- Early-stage neurotech with focused pipeline: two distinct indications (chronic migraine and cluster headache) for the same proprietary platform, reducing development dilution.
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
4 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
The Salvia PRIMUS implantable neurostimulator System
Chronic Cluster HeadacheClinical Trials (1)
NCT07113470Response to Combined Trigeminal and Occipital Nerve Stimulation for the Preventive Treatment in Chronic Cluster Headache
N/AHelp build intelligence for Salvia BioElectronics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.